Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Assessment for Progression to DMEK Following Cataract Surgery in Fuchs Endothelial Corneal Dystrophy
NCT04072029
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
NCT06966167
Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract
NCT01726543
Fuchs' Torsional Phaco Study
NCT00781027
Staged and Combined Surgery for Cataract Patients With Corneal Endothelial Dysfunction
NCT02523950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Descemetorhexis
Descemetorhexis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Descemetorhexis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide informed consent
* Fuchs' corneal dystrophy diagnosed
* Cataract present
* Best corrected visual acuity ≤ 20/40
* Candidate for current endothelial transplant procedure (DSAEK, DMEK)
Exclusion Criteria
* Medically unstable patient
* Monocular patient
* Unwilling or unable to provide informed consent
* Corneal dystrophy other than Fuchs'
* Central corneal scar or central opacity not related to Fuchs'
* Severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy
* History of prior vitreoretinal surgery
* Advanced or unstable glaucoma
* Known steroid responders with glaucoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical College of Wisconsin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steve Koenig
Steven B. Koenig, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCW-EI-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.